Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Biological drugs

The research program for protein research, method development and production of biological drugs offered Vinnova opportunity to seek funding for the project that contribute to better health.

This web page has been machine translated. If there are any uncertainties, please refer to the Swedish text.

Background to the investment

The Government has commissioned Vinnova and the Swedish Research Council to jointly design a national programme for protein research, method development and production of biological drugs.

The program is part of the government's strategic effort on health (life science) which together will contribute to better health, to meet societal challenges, strengthen Sweden's position as a leading country in research and development and increase Sweden's competitiveness in an international perspective.

The program refers to both research on proteins for future biological drugs and the development of more efficient methods for next-generation drug production.

The program runs from 2016 to 2023 and covers SEK 320 million.

See previous offers for funding

Funded project

Here you can read more about the project that Vinnova has previously financed in biological drugs.

Last updated 13 July 2021

Page statistics